Skip to main content
Log in

In vitro effects of the endocrine disruptor p,p′DDT on human choriogonadotropin/luteinizing hormone receptor signalling

  • In vitro systems
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Dichlorodiphenyltrichloroethane (p,p′DDT) is an endocrine-disrupting chemical (EDC). Several studies showed an association between p,p′DDT exposure and reprotoxic effects. We showed that p,p′DDT was a positive allosteric modulator of human follitropin receptor (FSHR). In contrast, we demonstrated that p,p′DDT decreased the cyclic AMP (cAMP) production induced by human choriogonadotropin (hCG). This study evaluated further the effects of p,p′DDT on Gs-, β-arrestin 2- and steroidogenesis pathways induced by hCG or luteinizing hormone (LH). We used Chinese hamster ovary cells line stably expressing hCG/LHR. The effects of 10–100 µM p,p′DDT on cAMP production and on β-arrestin 2 recruitment were measured using bioluminescence and time-resolved resonance energy transfer technology. The impact of 100 µM of p,p′DDT on steroid secretion was analysed in murine Leydig tumor cell line (mLTC-1). In cAMP assays, 100 µM p,p′DDT increased the EC50 by more than 300% and reduced the maximum response of the hCG/LHR to hCG and hLH by 30%. This inhibitory effect was also found in human granulosa cells line and in mLTC-1 cells. Likewise, 100 µM p,p′DDT decreased the hCG- and hLH-promoted β-arrestin 2 recruitment down to 14.2 and 26.6%, respectively. Moreover, 100 µM p,p′DDT decreased by 30 and 47% the progesterone secretion induced by hCG or hLH, respectively, without affecting testosterone secretion. This negative effect of p,p'DDT was independent of cytotoxicity. p,p′DDT acted as a negative allosteric modulator of the hCG/LHR signalling. This emphasizes the importance of analyzing all receptor-downstream pathways to fully understand the deleterious effects of EDC on human health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

GPCR:

G-protein-coupled receptor

DMSO:

Dimethyl sulfoxide

DDT:

Dichlorodiphenyltrichloroethane

LH:

Luteinizing hormone

hCG:

Human  choriogonadotropin

AC:

Adenylyl cyclase

PKA:

Protein kinase A

EPAC:

Exchange Protein Activated by cAMP

FSH:

Follicle stimulating hormone

BRET:

Bioluminescence and time-resolved resonance energy transfer

V2R:

Vasopressin 2 receptor

References

Download references

Acknowledgements

We thank Yves Combarnous (INRA-CNRS Nouzilly, Physiologie de la Reproduction et des comportements) for generously giving us the mLTC-1 cells line and Nadine Binart (Inserm U1185, Université Paris-Sud) for generously giving us the KGN cell line.

Funding

The authors did not receive support from any organization for the submitted work.

Author information

Authors and Affiliations

Authors

Contributions

MM and MA conceived the study, performed research, analyzed data and wrote the paper; VS and DH wrote the paper; LG performed research; ER and PR conceived study and wrote the paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mathilde Munier.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 742 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Munier, M., Ayoub, M., Suteau, V. et al. In vitro effects of the endocrine disruptor p,p′DDT on human choriogonadotropin/luteinizing hormone receptor signalling. Arch Toxicol 95, 1671–1681 (2021). https://doi.org/10.1007/s00204-021-03007-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-021-03007-1

Keywords

Navigation